GUANGZHOU, China–(BUSINESS WIRE)–$XPEV #EV–Xpeng Inc. (�Xpeng or the Company, NYSE: XPEV), a leading Chinese smart electric vehicle (Smart EV) company, today announced its vehicle delivery results for November 2020.
Xpeng delivered a total of 4,224 Smart EVs in November 2020, consisting of 2,732 P7s, the Companys smart sports sedan, and 1,492 G3s, its smart compact SUV. The Companys November deliveries represented a 342% increase year-over-year.
As of November 30, 2020, year-to-date deliveries of the Companys Smart EVs reached 21,341 units, representing an 87% increase year-over-year.
The Company delivered a total of 11,371 P7s year-to-date, five months after beginning mass delivery of the P7 at the end of June this year.
About Xpeng
Xpeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets Smart EVs that appeal to the large and growing base of technology-savvy middle-class consumers in China. Its mission is to drive Smart EV transformation with technology and data, shaping the mobility experience of the future. In order to optimize its customers mobility experience, Xpeng develops in-house its full-stack autonomous driving technology and in-car intelligent operating system, as well as core vehicle systems including powertrain and the electrification/electronic architecture. Xpeng is headquartered in Guangzhou, China, with offices in Beijing, Shanghai, Silicon Valley and San Diego. The Companys Smart EVs are manufactured at plants in Zhaoqing and Zhengzhou, located in Guangdong and Henan provinces, respectively. For more information, please visit https://en.xiaopeng.com.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as will, expects, anticipates, future, intends, plans, believes, estimates and similar statements. Statements that are not historical facts, including statements about Xpengs beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Xpengs goal and strategies; Xpengs expansion plans; Xpengs future business development, financial condition and results of operations; the trends in, and size of, Chinas EV market; Xpengs expectations regarding demand for, and market acceptance of, its products and services; Xpengs expectations regarding its relationships with customers, contract manufacturer, suppliers, third-party service providers, strategic partners and other stakeholders; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in Xpengs filings with the SEC. All information provided in this press release is as of the date of this press release, and Xpeng does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Contacts
For Investor Enquiries:
IR Department
Xpeng Inc.
E-mail: ir@xiaopeng.com
Jenny Cai
The Piacente Group
Tel: +1-212-481-2050 or +86-10-6508-0677
E-mail: Xpeng@tpg-ir.com
For Media Enquiries:
Marie Cheung
Xpeng Inc.
Tel: +852-9750-5170 or +86-1550-7577-546
E-mail: mariecheung@xiaopeng.com
ZHENGZHOU, China--(BUSINESS WIRE)--In central China’s Zhengzhou city, visiting museums has become a new trend of…
Mollie Pearce, star of the UK reality TV show ‘The Traitors’ who was diagnosed with…
QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…
SINGAPORE - Media OutReach Newswire - 17 May 2024 - UXLINK, the Web3 social platform…
DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…
Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…